loadpatents
name:-0.0058860778808594
name:-0.023739099502563
name:-0.00062084197998047
Griffith; Owen W Patent Filings

Griffith; Owen W

Patent Applications and Registrations

Patent applications and USPTO patent grants for Griffith; Owen W.The latest application filed is for "bifunctional enzyme with y-glutamylcysteine synthetase and glutathione synthetase activity and uses thereof".

Company Profile
0.21.6
  • Griffith; Owen W - Milwaukee WI
  • Griffith; Owen W. - Milwaukee WI
  • Griffith; Owen W. - New York NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bifunctional Enzyme with Y-Glutamylcysteine Synthetase and Glutathione Synthetase Activity and Uses Thereof
App 20080194701 - Griffith; Owen W. ;   et al.
2008-08-14
Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
Grant 7,022,737 - Stamler , et al. April 4, 2
2006-04-04
Anti-microbial agents derived from methionine sulfoximine analogues
App 20040157802 - Horwitz, Marcus ;   et al.
2004-08-12
Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
App 20030207815 - Stamler, Jonathan S. ;   et al.
2003-11-06
Treating asthma by preventing and/or accomodating for S-nitrosothiol breakdown
App 20030170316 - Gaston, Benjamin ;   et al.
2003-09-11
Treating asthma by preventing and/or accomodating S-nitrosothiol breakdown
Grant 6,617,355 - Gaston , et al. September 9, 2
2003-09-09
Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
Grant 6,608,110 - Stamler , et al. August 19, 2
2003-08-19
Manipulating Nitrosative Stress To Kill Pathologic Microbes, Pathologic Helminths And Pathologically Proliferating Cells Or To Upregulate Nitrosative Stress Defenses
App 20030096870 - Stamler, Jonathan S. ;   et al.
2003-05-22
Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase
Grant 6,231,894 - Stamler , et al. May 15, 2
2001-05-15
Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically, proliferating cells or to upregulate nitrosative stress defenses
Grant 6,180,824 - Stamler , et al. January 30, 2
2001-01-30
Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
Grant 6,057,367 - Stamler , et al. May 2, 2
2000-05-02
Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction
Grant 5,723,448 - Gross , et al. March 3, 1
1998-03-03
Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction
Grant 5,545,625 - Gross , et al. August 13, 1
1996-08-13
N.sup.6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body
Grant 5,436,271 - Griffith July 25, 1
1995-07-25
Heme binding compounds and use thereof
Grant 5,424,447 - Griffith , et al. June 13, 1
1995-06-13
Use of arginase to control nitric oxide formation
Grant 5,419,901 - Griffith * May 30, 1
1995-05-30
Method for treating systemic hypotension caused by sepsis or cytokine using arginase in combination with an .alpha..sub.1 adrenergic agonist
Grant 5,395,612 - Griffith , et al. March 7, 1
1995-03-07
Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension
Grant 5,312,835 - Kilbourn , et al. * May 17, 1
1994-05-17
L-buthionine-S-sulfoximine and methods of making
Grant 5,294,736 - Griffith March 15, 1
1994-03-15
Parenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
Grant 5,286,739 - Kilbourn , et al. February 15, 1
1994-02-15
Substituted arginines and substituted homoarginines and use thereof
Grant 5,281,627 - Griffith January 25, 1
1994-01-25
N.sup.6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body
Grant 5,273,875 - Griffith December 28, 1
1993-12-28
Use of arginase to control nitric oxide formation
Grant 5,196,195 - Griffith March 23, 1
1993-03-23
N.sup.6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body
Grant 5,132,453 - Griffith July 21, 1
1992-07-21
Isolating aminoarginine and use to block nitric oxide formation in body
Grant 5,059,712 - Griffith October 22, 1
1991-10-22
Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
Grant 5,028,627 - Kilbourn , et al. July 2, 1
1991-07-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed